Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 March 2008, Vol. 111, No. 5, pp. 2942-2943.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beltrami, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beltrami, C. A.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

CORRESPONDENCE

Life is plastic

To the editor:

Paolo Bianco's comment, "Life in plastic is fantastic," criticizes our paper "Multipotent cells can be generated in vitro from several adult human organs (heart, liver, and bone marrow)" from many standpoints. Our article1 describes a method to generate in vitro, from many human tissues, a population of cells characterized by: extensive proliferative capacity, high telomerase activity, and expression of both pluripotent state-specific transcription factors and pathways crucial for self-renewal. Furthermore, these cells, named human Multipotent Adult Stem Cells (hMASCs), displayed clonogenicity and multipotency.

In Bianco's opinion there are 4 major criticisms: (1) Cells are improperly defined as stem cells because self-renewal was not shown in vivo. (2) Clonogenicity and multipotency can be simply contingent on in vitro growth. (3) Only cells that acquire a differentiation phenotype in vivo are important, while those differentiated ex vivo and implanted are not of clinical value. (4) Considering these cells for clinical application "may be less than prudent."

(1) Regarding in vivo self-renewal, if this assay is mandatory to define a cell as a stem cell, the only entities that would satisfy this criterion, apart from embryonal carcinoma cells, embryonic stem cells (ES), and embryonic germ cells, are hematopoietic stem cells, spermatogonial stem cells,2 and tumor initiating cells.3 This raises the semantic question on how to define cells showing either the in vitro properties of hMASCs or cells for which, in addition, it has been shown a robust in vivo engraftment (eg, mesenchymal stem cells [MSCs],4 cardiac stem cells,5 etc).

(2) Considering multipotency, first it is imperative to specify that we demonstrated it at both polyclonal and clonal levels, excluding its contingency on clonal growth. Moreover, differentiation was not only demonstrated by "the expression of divergent differentiation markers," but documenting the acquisition of specific functional activities (ie, among the others, spontaneous contractile activity for myocytes, voltage dependent ionic currents for neural cells, albumin release for hepatic cells). Bearing in mind this elucidation, we would like to underline that our paper does not deal with the existence, in postnatal tissues, of cells with transgermal potential, as stated by Dr Bianco, but with the possibility to generate, in culture, from human adult tissues, cells characterized by a robustly proven ability to differentiate into multiple functionally competent cell types.

(3) To dismiss the importance of generating cells predifferentiated in vitro for regenerative purposes would be in contrast with many works that use ES-derived mature cells to treat diseases ranging from Parkinson to myocardial infarction or that use cells in engineered tissues.6 Moreover, we agree that, from a theoretical point of view, "a cell pushed to express hepatocyte features might not survive if transplanted in vivo," but recent data on MSCs used for liver regeneration point in the opposite direction.7

(4) Finally, we agree with the statement that the immediate translation of hMASC use from the in vitro assays to clinical settings is, at present, less than prudent. Confidence on their safety and usefulness will require extensive in vivo animal studies, such as those that are ongoing in our laboratory. Therefore, before expressing a priori preconceptions, it will be better to wait for in vivo data.

Authorship

Conflict-of-interest disclosure: The author declares no competing financial interests.

Correspondence: Carlo A. Beltrami, Dipartimento di Ricerche Mediche e Morfologiche, Istituto di Anatomia Patologica, Udine 33100, Italy; e-mail: beltrami{at}uniud.it.

Carlo A. Beltrami

References

  1. Beltrami AP, Cesselli D, Bergamin N, et al. Multipotent cells can be generated in vitro from several adult human organs (heart, liver, and bone marrow). Blood 2007; 110:3438–3446.[Abstract/Free Full Text]

  2. Guan K, Nayernia K, Maier LS, et al. Pluripotency of spermatogonial stem cells from adult mouse testis. Nature 2006; 440:1199–1203.[CrossRef][Medline] [Order article via Infotrieve]

  3. Huntly BJ and Gilliland DG. Cancer biology: summing up cancer stem cells. Nature 2005; 435:1169–1170.[CrossRef][Medline] [Order article via Infotrieve]

  4. Pittenger MF and Martin BJ. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 2004; 95:9–20.[Abstract/Free Full Text]

  5. Beltrami AP, Barlucchi L, Torella D, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003; 114:763–776.[CrossRef][Medline] [Order article via Infotrieve]

  6. Wobus AM and Boheler KR. Embryonic stem cells: prospects for developmental biology and cell therapy. Physiol Rev 2005; 85:635–678.[Abstract/Free Full Text]

  7. Sgodda M, Aurich H, Kleist S, et al. Hepatocyte differentiation of mesenchymal stem cells from rat peritoneal adipose tissue in vitro and in vivo. Exp Cell Res 2007; 313:2875–2886.[CrossRef][Medline] [Order article via Infotrieve]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

Life in plastic is fantastic
Paolo Bianco
Blood 2007 110: 3090. [Full Text] [PDF]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beltrami, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beltrami, C. A.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2008 by American Society of Hematology         Online ISSN: 1528-0020